Literature DB >> 18303186

Role of TNF-alpha and extracellular ATP in THP-1 cell activation following allergen exposure.

Masaaki Miyazawa1, Yuichi Ito, Nanae Kosaka, Yuko Nukada, Hitoshi Sakaguchi, Hiroyuki Suzuki, Naohiro Nishiyama.   

Abstract

Dendritic cells (DCs), including Langerhans cells (LCs), play a critical role in the induction phase of allergic contact hypersensitivity. Following exposure to chemical allergens in the skin, LCs undergo a maturation process leading to the up-regulation of expression of co-stimulatory molecules, such as CD86, CD54 and CD40. Our previous study revealed that chemical allergens induce phenotype alterations (e.g., CD86, CD54 and CD40) and cytokine production (TNF-alpha and IL-8) in THP-1 cells that possibly reflect the maturation of dendritic cells during skin sensitization. However, the physiological signals for phenotypic alterations by chemical allergens are still not fully understood. Therefore, in this study, we investigated the effect of TNF-alpha and extracellular ATP on THP-1 cell activation induced by chemical allergens. Kinetic studies revealed that TNF-alpha and IL-8 release occurred in a time-dependent manner with release of two cytokines beginning at 3 hr post-exposure to well-known haptens, DNCB and NiSO(4). While recombinant human TNF-alpha augmented CD54 and CD40 expression in a dose-dependent manner, rhTNF-alpha did not increase CD86 expression. Furthermore, neutralization of TNF-alpha activity strongly inhibited CD54 and CD40 expression induced by allergens. On the contrary, extracellular ATP induced the up-regulation of both CD86 and CD54 expression. In the presence of the P2 receptor antagonist suramin, the up-regulation of CD86 and CD54 expression by allergens was in part suppressed. Therefore, we postulate that not only TNF-alpha but also extracellular ATP may contribute to cell activation following allergen stimulation, which might reflect the mechanism by which DCs respond to allergens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303186     DOI: 10.2131/jts.33.71

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  7 in total

1.  Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.

Authors:  Emilio Margolles-Clark; Oliver Umland; Norma S Kenyon; Camillo Ricordi; Peter Buchwald
Journal:  J Mol Med (Berl)       Date:  2009-08-26       Impact factor: 4.599

2.  Adenosine diphosphate involvement in THP-1 maturation triggered by the contact allergen 1-fluoro-2,4-dinitrobenzene.

Authors:  J D Martins; A Silva; I Ferreira; M Gonçalo; J B A Custódio; M C Lopes; M R M Domingues; B M Neves; M T Cruz
Journal:  Toxicol Res (Camb)       Date:  2016-08-04       Impact factor: 3.524

Review 3.  Danger signals activating innate immunity in graft-versus-host disease.

Authors:  Robert Zeiser; Olaf Penack; Ernst Holler; Marco Idzko
Journal:  J Mol Med (Berl)       Date:  2011-05-15       Impact factor: 4.599

4.  Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Authors:  Nripen S Sharma; Rohit Jindal; Bhaskar Mitra; Serom Lee; Lulu Li; Tim J Maguire; Rene Schloss; Martin L Yarmush
Journal:  Cell Mol Bioeng       Date:  2012-03       Impact factor: 2.321

5.  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.

Authors:  Jinshui Chen; Yun Song; Damir Bojadzic; Alejandro Tamayo-Garcia; Ana Marie Landin; Bonnie B Blomberg; Peter Buchwald
Journal:  J Med Chem       Date:  2017-10-25       Impact factor: 7.446

6.  Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro.

Authors:  Sylvain Michée; Françoise Brignole-Baudouin; Luisa Riancho; William Rostene; Christophe Baudouin; Antoine Labbé
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

Review 7.  Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10.

Authors:  Dmitriy Minond
Journal:  Front Mol Biosci       Date:  2020-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.